Aruldhas BW, Hoglund RM, Ranjalkar J, Tarning J, Mathew SK, Verghese VP, Bose A, Mathew BS. Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India. Br J Clin Pharmacol. 2019 Mar;85(3):644-654. doi: 10.1111/bcp.13846. Epub 2019 Jan 17. PMID: 30588647; PMCID: PMC6379231.

Ranjalkar J, Mathew SK, Verghese VP, Bose A, Rose W, Gupta D, Fleming DH, Mathew BS. Isoniazid and rifampicin concentrations in children with tuberculosis with either a daily or intermittent regimen: implications for the revised RNTCP 2012 doses in India. Int J Antimicrob Agents. 2018 May;51(5):663-669. doi: 10.1016/j.ijantimicag.2017.12.004. Epub 2017 Dec 11. PMID: 29241821.

Margaret Shanthi FX*, Blessed Winston A, Aniket Kumar Evaluation of Efficacy of Tutorials in Pharmacology for 2nd year undergraduate Medical Students in India Research J. Pharm. and Tech. 9(2): February 2016: 152-57

Chandy SJ, Ranjalkar J, Chandy SS. Collateral effects and ethical challenges in healthcare due to COVID-19 - A dire need to support healthcare workers and systems. J Family Med Prim Care. 2021 Jan;10(1):22-26. doi: 10.4103/jfmpc.jfmpc_1653_20. Epub 2021 Jan 30. PMID: 34017697; PMCID: PMC8132839.

Ranjalkar J, Jhaj R, Chandy SJ, Ight HR, Chugh PK, Tripathi CD, Badyal DK, Balakrishnan S, Medhi B, Kamat SK, Tripathi R, Dikshit H, Roy SS, Chatterjee S, Bhattacharjee M, Trivedi N, Desai C, Gupta P, Roy A, Raveendran R, Mathaiyan J, Kaushal S, Jain S, Kaul R, Kshirsagar NA. Usage Pattern of Fixed-dose Combinations at ICMR Network of Rational Use of Medicine Centres across India: Recommendations for Policymakers and Prescribers . J Assoc Physicians India. 2023 Feb;71(2):11-12. doi: 10.5005/japi-11001-0175. PMID: 37354468.

Mathew P, Ranjalkar J, Chandy SJ. Challenges in Implementing Antimicrobial Stewardship Programmes at Secondary Level Hospitals in India: An Exploratory Study. Front Public Health. 2020 Sep 18;8:493904. doi: 10.3389/fpubh.2020.493904. PMID: 33072690; PMCID: PMC7531198.

Aruldhas BW, Hoglund RM, Ranjalkar J, Tarning J, Mathew SK, Verghese VP, Bose A, Mathew BS. Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India. Br J Clin Pharmacol. 2019 Mar;85(3):644-654. doi: 10.1111/bcp.13846. Epub 2019 Jan 17. PMID: 30588647; PMCID: PMC6379231.

Ranjalkar J, Mathew SK, Verghese VP, Bose A, Rose W, Gupta D, Fleming DH, Mathew BS. Isoniazid and rifampicin concentrations in children with tuberculosis with either a daily or intermittent regimen: implications for the revised RNTCP 2012 doses in India. Int J Antimicrob Agents. 2018 May;51(5):663-669. doi: 10.1016/j.ijantimicag.2017.12.004. Epub 2017 Dec 11. PMID: 29241821.

Margaret Shanthi FX*, Blessed Winston A, Aniket Kumar Evaluation of Efficacy of Tutorials in Pharmacology for 2nd year undergraduate Medical Students in India Research J. Pharm. and Tech. 9(2): February 2016: 152-57

Chandy SJ, Ranjalkar J, Chandy SS. Collateral effects and ethical challenges in healthcare due to COVID-19 - A dire need to support healthcare workers and systems. J Family Med Prim Care. 2021 Jan;10(1):22-26. doi: 10.4103/jfmpc.jfmpc_1653_20. Epub 2021 Jan 30. PMID: 34017697; PMCID: PMC8132839.

Ranjalkar J, Jhaj R, Chandy SJ, Ight HR, Chugh PK, Tripathi CD, Badyal DK, Balakrishnan S, Medhi B, Kamat SK, Tripathi R, Dikshit H, Roy SS, Chatterjee S, Bhattacharjee M, Trivedi N, Desai C, Gupta P, Roy A, Raveendran R, Mathaiyan J, Kaushal S, Jain S, Kaul R, Kshirsagar NA. Usage Pattern of Fixed-dose Combinations at ICMR Network of Rational Use of Medicine Centres across India: Recommendations for Policymakers and Prescribers . J Assoc Physicians India. 2023 Feb;71(2):11-12. doi: 10.5005/japi-11001-0175. PMID: 37354468.

Mathew P, Ranjalkar J, Chandy SJ. Challenges in Implementing Antimicrobial Stewardship Programmes at Secondary Level Hospitals in India: An Exploratory Study. Front Public Health. 2020 Sep 18;8:493904. doi: 10.3389/fpubh.2020.493904. PMID: 33072690; PMCID: PMC7531198.

Ranjalkar J, Chandy SJ. India's National Action Plan for antimicrobial resistance - An overview of the context, status, and way ahead. J Family Med Prim Care. 2019 Jun;8(6):1828-1834. doi: 10.4103/jfmpc.jfmpc_275_19. PMID: 31334140; PMCID: PMC6618210.

Joshi R, Medhi B, Prakash A, Chandy S, Ranjalkar J, Bright HR, Basker J, Govindraj L, Chugh PK, Tripathi CD, Badyal DK, Balakrishnan S, Jhaj R, Shukla AK, Atal S, Najmi A, Banerjee A, Kamat S, Tripathi RK, Shetty YC, Parmar U, Rege N, Dikshit H, Mishra H, Roy SS, Chatterjee S, Hazra A, Bhattacharya M, Das D, Trivedi N, Shah P, Chauhan J, Desai C, Gandhi AM, Patel PP, Shah S, Sheth S, Raveendran R, Mathaiyan J, Manikandan S, Jeevitha G, Gupta P, Sarangi SC, Yadav HN, Singh S, Kaushal S, Arora S, Gupta K, Jain S, Cherian JJ, Chatterjee NS, Kaul R, Kshirsagar NA. Assessment of prescribing pattern of drugs and completeness of prescriptions as per the World Health Organization prescribing indicators in various Indian tertiary care centers: A multicentric study by Rational Use of Medicines Centers-Indian Council of Medical Research network under National Virtual Centre Clinical Pharmacology activity. Indian J Pharmacol. 2022 Sep-Oct;54(5):321-328. doi: 10.4103/ijp.ijp_976_21. PMID: 36537400; PMCID: PMC9846909.

Gafar F, Wasmann RE, McIlleron HM, Aarnoutse RE, Schaaf HS, Marais BJ, Agarwal D, Antwi S, Bang ND, Bekker A, Bell DJ, Chabala C, Choo L, Davies GR, Day JN, Dayal R, Denti P, Donald PR, Engidawork E, Garcia-Prats AJ, Gibb D, Graham SM, Hesseling AC, Heysell SK, Idris MI, Kabra SK, Kinikar A, Kumar AKH, Kwara A, Lodha R, Magis-Escurra C, Martinez N, Mathew BS, Mave V, Mduma E, Mlotha-Mitole R, Mpagama SG, Mukherjee A, Nataprawira HM, Peloquin CA, Pouplin T, Ramachandran G, Ranjalkar J, Roy V, Ruslami R, Shah I, Singh Y, Sturkenboom MGG, Svensson EM, Swaminathan S, Thatte U, Thee S, Thomas TA, Tikiso T, Touw DJ, Turkova A, Velpandian T, Verhagen LM, Winckler JL, Yang H, Yunivita V, Taxis K, Stevens J, Alffenaar JC; Global Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in Pharmacokinetics of Anti-TB Drugs. Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis. Eur Respir J. 2023 Mar 9;61(3):2201596. doi: 10.1183/13993003.01596-2022. PMID: 36328357; PMCID: PMC9996834.

Thomas SA, Mathew P, Ranjalkar J, Nguyen TBV, Giao VTQ, Chandy SJ. Public perception and community-level impact of national action plans on antimicrobial resistance in Vietnam. JAC Antimicrob Resist. 2023 Dec 28;6(1):dlad146. doi: 10.1093/jacamr/dlad146. PMID: 38161968; PMCID: PMC10753920.

Mathew P, Chandy SJ, Sivaraman S, Ranjalkar J, Ali HM, Thomas SA. Formulating a Community-Centric Indicator Framework to Quantify One Health Drivers of Antibiotic Resistance: A Preliminary Step towards Fostering 'Antibiotic-Smart Communities'. Antibiotics (Basel). 2024 Jan 8;13(1):63. doi: 10.3390/antibiotics13010063. PMID: 38247622; PMCID: PMC10812418.

Shetty Y, Kamat S, Tripathi R, Parmar U, Jhaj R, Banerjee A, Balakrishnan S, Trivedi N, Chauhan J, Chugh PK, Tripathi CD, Badyal DK, Solomon L, Kaushal S, Gupta K, Jayanthi M, Jeevitha G, Chatterjee S, Samanta K, Desai C, Shah S, Medhi B, Joshi R, Prakash A, Gupta P, Roy A, Chandy S, Ranjalkar J, Bright HR, Dikshit H, Mishra H, Roy SS, Kshirsagar N. Evaluation of prescriptions from tertiary care hospitals across India for deviations from treatment guidelines & their potential consequences. Indian J Med Res. 2024 Feb 1;159(2):130-141. doi: 10.4103/ijmr.ijmr_2309_22. Epub 2024 Apr 4. PMID: 38528817.

Dinesh B, J CS, Kaur CP, Atiya F, Yk G, Avijit H, Sandhya K, Vp K, Rajani K, Nilima K, Subir M, Bikash M, Geetha M, Jaya R, Vishnu R, Yashashri S, Raakhi T, Denis X. Hydroxychloroquine for SARS CoV2 Prophylaxis in Healthcare Workers - A Multicentric Cohort Study Assessing Effectiveness and Safety. J Assoc Physicians India. 2021 Jun;69(6):11-12. PMID: 34472778.

Ranganathan R, Ranjalkar J. Potential role of civil society organizations (CSOs) in antimicrobial resistance (AMR) mitigation efforts in low- and middle-income countries: A report from India. J Infect Public Health. 2023 Dec;16 Suppl 1:125-128. doi: 10.1016/j.jiph.2023.10.043. Epub 2023 Nov 2. PMID: 37973495.

Mathew P, Chandy SJ, Ranjalkar J. Community engagement to mitigate antimicrobial resistance in low-and middle-income countries - an essential strategy for implementation of national action plans on AMR. Lancet Reg Health Southeast Asia. 2024 Mar 14;24:100379. doi: 10.1016/j.lansea.2024.100379. PMID: 38510334; PMCID: PMC10951515.

Chugh PK, Gupta P, Wasan H, Tripathi CD, Chandy SJ, Ranjalkar J, Bright HR, Badyal DK, Samuel MP, Jhaj R, Banerjee A, Joshi R, Medhi B, Prakash A, Kamat S, Tripathi R, Shetty Y, Parmar U, Dikshit H, Mishra H, Roy SS, Kumar R, Chatterjee S, Bhattacharya M, Samanta K, Trivedi N, Shah P, Chauhan J, Ramasamy R, Mathaiyan J, Gauthaman J, Kaushal S, Jain S, Arora S, Gupta K, Cherian JJ, Chatterjee NS, Kshirsagar NA. Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India. Indian J Pharmacol. 2024 Mar 1;56(2):97-104. doi: 10.4103/ijp.ijp_61_23. Epub 2024 Apr 30. PMID: 38687313; PMCID: PMC11161000.

Ranjalkar J, Wilfred PM, Priya R. Letter to the editor-Response to the article "Drug-induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis". Br J Clin Pharmacol. 2025 May;91(5):1518-1519. doi: 10.1002/bcp.70038. Epub 2025 Mar 4. PMID: 40040374.

Wilfred PM, Ranjalkar J, Chandy SJ. Steering medicines towards patient safety: Challenges and possible solutions. Indian J Med Ethics. 2026 Jul-Sep;XI(3):224-229. doi: 10.20529/IJME.2025.090. Epub 2025 Nov 29. PMID: 41801694.